Pharma Journalist -

SMi Reports: Explore a future outlook of the industry with insights from leading start-ups and thought leaders on novel developments in digital medicine. In light of the global…
Read More...

SMi Group reports: Richard Denk, SKAN AG speaker and co-chair at SMi ‘s Aseptic Processing Conference in September 2021 exclusive interview released. The inaugural Aseptic Processing…
Read More...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health…
Read More...

SPI Pharma introduces UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics — dissolution time. It is an innovative excipient…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in …
Read More...

NRx Pharmaceuticals a clinical stage pharmaceutical company announced that it has signed a Memorandum Of Understanding with the Government of Israel to license exclusive worldwide…
Read More...

SMi Group reports: Gain insights into developments in wearable devices in clinical trials and adapting to decentralised trials during the pandemic Wearable Injectors and Connected…
Read More...

Microbiome Connect Gut Therapeutics returns on November 17-18 for its sixth iteration; in-person, in Boston - featuring a new for 2021, dedicated manufacturing stream. 2020 was an…
Read More...

I-Mab a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the signing of two new collaborations with…
Read More...

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration…
Read More...